Boyer C - Search Results

1

Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines.

Desplat V, Belloc F, Lagarde V, Boyer C, Melo JV, Reiffers J, Praloran V, Mahon FX. Desplat V, et al. Among authors: boyer c. Cancer. 2005 Jan 1;103(1):102-10. doi: 10.1002/cncr.20758. Cancer. 2005. PMID: 15558795 Free article.

2

Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation.

Cotteret S, Belloc F, Boiron JM, Bilhou-Nabera C, Dumain P, Boyer C, Lacombe F, Reiffers J, Bernard P. Cotteret S, et al. Among authors: boyer c. Cytometry. 1998 Oct 15;34(5):216-22. Cytometry. 1998. PMID: 9822307

3

Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines.

Boyer CM, Dawson DV, Neal SE, Winchell LF, Leslie DS, Ring D, Bast RC Jr. Boyer CM, et al. Cancer Res. 1989 Jun 1;49(11):2928-34. Cancer Res. 1989. PMID: 2497969

4

Expression of cell regulatory proteins in ovarian borderline tumors.

van Haaften-Day C, Russell P, Boyer CM, Kerns BJ, Wiener JR, Jensen DN, Bast RC Jr, Hacker NF. van Haaften-Day C, et al. Among authors: boyer cm. Cancer. 1996 May 15;77(10):2092-8. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2092::AID-CNCR19>3.0.CO;2-Q. Cancer. 1996. PMID: 8640675

5

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.

Olt G, Berchuck A, Soisson AP, Boyer CM, Bast RC Jr. Olt G, et al. Among authors: boyer cm. Cancer. 1992 Oct 15;70(8):2137-42. doi: 10.1002/1097-0142(19921015)70:8<2137::aid-cncr2820700821>3.0.co;2-w. Cancer. 1992. PMID: 1394043

6

Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.

Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC Jr. Wu S, et al. Among authors: boyer cm. Cancer Res. 1993 Apr 15;53(8):1939-44. Cancer Res. 1993. PMID: 8385577

7

A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell lines.

Crews JR, Maier LA, Yu YH, Hester S, O'Briant K, Leslie DS, DeSombre K, George SL, Boyer CM, Argon Y, et al. Crews JR, et al. Among authors: boyer cm. Int J Cancer. 1992 Jul 9;51(5):772-9. doi: 10.1002/ijc.2910510518. Int J Cancer. 1992. PMID: 1351885

8

The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin.

Xu FJ, Boyer CM, Bae DS, Wu S, Greenwald M, O'Briant K, Yu YH, Mills GB, Bast RC Jr. Xu FJ, et al. Among authors: boyer cm. Int J Cancer. 1994 Oct 15;59(2):242-7. doi: 10.1002/ijc.2910590217. Int J Cancer. 1994. PMID: 7927925

9

Cell growth regulation in epithelial ovarian cancer.

Bast RC Jr, Boyer CM, Jacobs I, Xu FJ, Wu S, Wiener J, Kohler M, Berchuck A. Bast RC Jr, et al. Among authors: boyer cm. Cancer. 1993 Feb 15;71(4 Suppl):1597-601. doi: 10.1002/cncr.2820710426. Cancer. 1993. PMID: 8431895 Review.

10

Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.

Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y, Bast RC Jr. Maier LA, et al. Among authors: boyer cm. Cancer Res. 1991 Oct 1;51(19):5361-9. Cancer Res. 1991. PMID: 1680547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

941 results

Search Page

Filters